iShares Biotechnology ETF
428 hedge funds and large institutions have $3.72B invested in iShares Biotechnology ETF in 2016 Q2 according to their latest regulatory filings, with 71 funds opening new positions, 149 increasing their positions, 122 reducing their positions, and 52 closing their positions.
Holders
428
Holders Change
+14
Holders Change %
+3.38%
% of All Funds
11.44%
Holding in Top 10
20
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-4.76%
% of All Funds
0.53%
New
71
Increased
149
Reduced
122
Closed
52
Calls
$629M
Puts
$1.39B
Net Calls
-$762M
Net Calls Change
-$469M
Top Buyers
| 1 |
1
JPMorgan Chase & Co
New York
|
$140M |
| 2 |
2
BNP Paribas Financial Markets
Paris,
France
|
$344M |
| 3 |
3
Bank of America
Charlotte,
North Carolina
|
$665M |
| 4 |
SG
4
Societe Generale
|
$63.1M |
| 5 |
5
Citadel Advisors
Miami,
Florida
|
$55M |
Top Sellers
| 1 |
1
Citigroup
New York
|
$278M |
| 2 |
2
Morgan Stanley
New York
|
$224M |
| 3 |
3
Goldman Sachs
New York
|
$437M |
| 4 |
4
LPL Financial
San Diego,
California
|
$1.43M |
| 5 |
5
Jane Street
New York
|
$392K |
